Doctors and the medical profession are facing some troubling issues as clinical trials
sponsored by the pharmaceutical industry migrate from academic settings into the …

After parting ways in the late 90s, academic medical centers are revisiting industry-
sponsored clinical trials. he privatization of clinical research is widely known. Up until the …

Industry-Sponsored Clinical Research: A Broken System ing compliance and good will. The
new policies lose their controversial character rather quickly. The faculty moves on—and this …

Recently at an impromptu meeting of community oncologists, discussions moved to the topic
of clinical trials. In our nonrandomized and nonstatistically representative group, every …

Daniel P. Schuster and Janet McGill uring the early 1990s, academic medical centers
conducted most industry-sponsored clinical trials of new drugs and medical devices. In the …

THOUSANDS OF PHYSICIANS, PREDOMINANTLY IN PRI-mary care and oncology,
participate in commu-nity research networks sponsored by federal entities, industry, and …

Clinical trials now increasingly impinge on society at large. First there is growing emphasis
from health organizations on the need for unbiased evidence about the effectiveness of …

Participation in clinical trials is recommended as part of the clinical care for cancer patients
in most guidelines, yet patient accrual is poor [1]. Lack of awareness, understanding and …

Viewpoint fees were paid to centres for each patient recruited. These fees became
increasingly larger as companies “competed” to conduct trials. Second, the attitudes of …

In recent years, along with rapid growth in the number of trials testing new drugs or new
uses for existing drugs, a major shift has occurred in how these trials are funded and carried …